An interventional study of Advance care plan and Ergonomic analysis in Health Services for the Aged and Advance Care Planning, sponsored by Lille Catholic University. Recruiting at 6 sites in France. Open to participants aged 75 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by Lille Catholic University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study consists to evaluate the feasibility of a case-management intervention of Advance Care Plan (ACP) placement for elderly patients at high risk of death at twelve months discharged alive from acute geriatric medicine.
Feasibility will include the following indicators: rate of patients included and randomized, rate of patients remaining in the study, ACP rates achieved at one month.
Lille Catholic University is the lead sponsor of 112 studies on the registry; 24 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Scheduling of 2 home visits by an expert nurse in the month following the return home and proposal to carry out an advance care plan.
Other: Advance care plan · Other: Ergonomic analysis · Other: Evaluation of intervention acceptability
Usual care with the possibility of proposing ACP according to the department's habits
Scheduling of 2 home visits by an expert nurse in the month following the return home and proposal to carry out an advance care plan.
Ergonomic analysis throughout the intervention
Evaluation of intervention acceptability after each home visit with patients and caregivers using a questionnaire
Rate of included patients
Time frame: 12 months
Rate of patients remaining in the study
Time frame: 12 months
Advance care planning rate achieved
Time frame: 12 months
Rate of compliance to advance directives
Rate of compliance with the patient's advance directives one year after discharge from hospital; compliance to the the following situations will be identified: * The patient is still alive: wishes to be re-hospitalized / does not wish to be re-hospitalized / has not made a decision. * The patient is deceased: place of death specified: hospital, home or other / no decision taken.
Time frame: 12 months
Hospital Anxiety and Depression Scale (HADS) of caregivers and carers
Anxiety-depressive symptomatology of caregivers will be assessed using the Hospital Anxiety and Depression Scale (HADS) in the event of patient death, if this occurs within one year of discharge from hospital. The HAD scale is a screening instrument for anxiety and depressive disorders. It comprises 14 items rated from 0 to 3. Seven questions relate to anxiety (total A) and seven to depression (total D), giving two scores (maximum score for each = 21). To screen for anxiety and depressive symptoms, the following interpretation can be proposed for each of the scores (A and D) each of the scores (A and D): * 7 or less: no symptoms * 8 to 10: doubtful symptomatology - 11 or more: definite symptomatology.
Time frame: 12 months
Questionnaire to evaluate the acceptability of the intervention
The acceptability of the intervention will be assessed by a questionnaire after each home visit at 7 days and one month, with patients and caregivers in the intervention group.
Time frame: 12 months
EQ-5D-3L scale score
Changes in the quality of life of patients and caregivers one month after hospital discharge will be measured by changes in the EQ-5D-3L scale score. EQ-5D is a standardised measure of health-related quality of life.n EQ-5D-3L, the five dimensions each have three response levels of severity. Respondents are asked to choose the statement in each dimension that best describes their health status on the day they are surveyed. Their responses are coded as a number (1, 2, or 3) that corresponds to the respective level of severity: 1 indicates no problems, 2 some problems, and 3 extreme problems. In this way, a person's health state profile can be defined by a 5-digit number, ranging from 11111 (having no problems in any of the dimensions) to 33333 (having extreme problems in all the dimensions).
Time frame: 12 months
Plan to share: No
No publications or documents are linked to this record.
Started Jan 2025 (actual). Primary completion is estimated for May 2027, 28 months after the start.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 20, 2026: start Oct 2024 → Jan 2025, primary completion May 2026 → May 2027 and completion Oct 2027 → Oct 2029.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.